Low serum allopregnanolone is associated with symptoms of depression in late pregnancy

Neuropsychobiology

Volumn 69, Issue 3, 2014, Pages 147-153

  Hellgren, Charlotte ^a   Akerud, Helena ^a   Skalkidou, Alkistis ^a   Bäckström, Torbjörn ^b   Sundström Poromaa, Inger ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Allopregnanolone; Anxiety; Depression; Montgomery Asberg Depression Rating Scale; Pregnancy; Spielberger State Trait Anxiety Inventory

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; PROGESTERONE; ELTANOLONE;

ADULT; ANXIETY DISORDER; ARTICLE; CHROMATOGRAPHY; DEPRESSION; ESTRADIOL BLOOD LEVEL; FEMALE; GESTAGEN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NULLIPARA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PUERPERAL DEPRESSION; RADIOIMMUNOASSAY; STATE TRAIT ANXIETY INVENTORY; THIRD TRIMESTER PREGNANCY; DISEASE ASSOCIATION; OBSESSIVE COMPULSIVE DISORDER; ANXIETY; BLOOD; PREGNANCY; PREGNANCY COMPLICATION; SELF REPORT; YOUNG ADULT;

ADULT; ANXIETY; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PREGNANOLONE; SELF REPORT; YOUNG ADULT;

EID: 84899593528     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000358838     Document Type: Article

References (51)

1. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004-1007. (Pubitemid 16085410
2. Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, et al: Circulating levels of allopregnanolone in humans: Gender, age, and endocrine influences. J Clin Endocrinol Metab 1998; 83: 2099-2103. (Pubitemid 28496343
3. Ottander U, Poromaa IS, Bjurulf E, Skytt A, Backstrom T, Olofsson JI: Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol Cell Endocrinol 2005; 239: 37-44. (Pubitemid 40848727
4. Dombroski RA, Casey ML, MacDonald PC: 5-Alpha-dihydroprogesterone formation in human placenta from 5alpha-pregnan-3beta/ alpha-ol-20-ones and 5-pregnan-3beta-yl-20-one sulfate. J Steroid Biochem Mol Biol 1997; 63: 155-163. (Pubitemid 28018148
5. Luisi S, Petraglia F, Benedetto C, Nappi RE, Bernardi F, Fadalti M, et al: Serum allopregnanolone levels in pregnant women: Changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 2000; 85: 2429-2433. (Pubitemid 32269196
6. Parizek A, Hill M, Kancheva R, Havlikova H, Kancheva L, Cindr J, et al: Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 2005; 90: 395-403. (Pubitemid 40116687
7. Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR: Serum allopregnanolone in women with postpartum 'blues'. Obstet Gynecol 2001; 97: 77-80
8. Pearson Murphy BE, Steinberg SI, Hu FY, Allison CM: Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: Elevated levels of 5 alphadihydroprogesterone in Depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab 2001; 86: 5981-5987
9. Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J, et al: Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 2006; 186: 414-424. (Pubitemid 43800842
10. Kask K, Backstrom T, Nilsson LG, Sundstrom-Poromaa I: Allopregnanolone impairs episodic memory in healthy women. Psychopharmacology (Berl) 2008; 199: 161-168
11. Christensen H, Leach LS, Mackinnon A: Cognition in pregnancy and motherhood: Prospective cohort study. Br J Psychiatry 2010; 196: 126-132
12. Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F, et al: Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998; 155: 910-913. (Pubitemid 28307602
13. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, et al: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998; 95: 3239-3244. (Pubitemid 28135886
14. Schule C, Romeo E, Uzunov DP, Eser D, di Michele F, Baghai TC, et al: Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. Mol Psychiatry 2006; 11: 261-272
15. Baghai TC, di Michele F, Schule C, Eser D, Zwanzger P, Pasini A, et al: Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology 2005; 30: 1181-1186. (Pubitemid 40720977
16. Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS: Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 2006; 31: 1208-1219. (Pubitemid 44792370
17. Morgan ML, Rapkin AJ, Biggio G, Serra M, Pisu MG, Rasgon N: Neuroactive steroids after estrogen exposure in Depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. Arch Womens Ment Health 2010; 13: 91-98
18. Gulinello M, Orman R, Smith SS: Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 2003; 17: 641-648. (Pubitemid 36255901
19. Bitran D, Hilvers RJ, Kellogg CK: Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 1991; 561: 157-161
20. Brunton PJ, McKay AJ, Ochedalski T, Piastowska A, Rebas E, Lachowicz A, et al: Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J Neurosci 2009; 29: 6449-6460
21. de Brito Faturi C, Teixeira-Silva F, Leite JR: The anxiolytic effect of pregnancy in rats is reversed by finasteride. Pharmacol Biochem Behav 2006; 85: 569-574. (Pubitemid 46097068
22. Paoletti AM, Romagnino S, Contu R, Orru MM, Marotto MF, Zedda P, et al: Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. Psychoneuroendocrinology 2006; 31: 485-492. (Pubitemid 43375950
23. Bicikova M, Tallova J, Hill M, Krausova Z, Hampl R: Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. Neurochem Res 2000; 25: 1623-1627. (Pubitemid 32052022
24. Heydari B, Le Melledo JM: Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia. Psychol Med 2002; 32: 929-933. (Pubitemid 34823345
25. Le Melledo JM, Van Driel M, Coupland NJ, Lott P, Jhangri GS: Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry 2000; 157: 821-823. (Pubitemid 30249665
26. Semeniuk T, Jhangri GS, Le Melledo JM: Neuroactive steroid levels in patients with generalized anxiety disorder. J Neuropsychiatry Clin Neurosci 2001; 13: 396-398. (Pubitemid 32743719
27. Brambilla F, Biggio G, Pisu MG, Bellodi L, Perna G, Bogdanovich-Djukic V, et al: Neurosteroid secretion in panic disorder. Psychiatry Res 2003; 118: 107-116. (Pubitemid 36694424
28. Strohle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, et al: GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 2002; 159: 145-147. (Pubitemid 41070744
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33, quiz 34-57
30. Svanborg P, Asberg M: A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994; 89: 21-28. (Pubitemid 24028261
31. Spielberger CD: State-Trait Anxiety Inventory for Adults. Sampler Set, Manual Set, Scoring Key. Palo Alto, Consulting Psychologists Press Inc, 1983
32. Grant KA, McMahon C, Austin MP: Maternal anxiety during the transition to parenthood: A prospective study. J Affect Disord 2008; 108: 101-111. (Pubitemid 351418021
33. Cox JL, Holden JM, Sagovsky R: Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-786. (Pubitemid 17082036
34. Wickberg B, Hwang CP: The Edinburgh Postnatal Depression Scale: Validation on a Swedish community sample. Acta Psychiatr Scand 1996; 94: 181-184. (Pubitemid 26313290
35. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, et al: Brain 5alphadihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 2001; 98: 2849-2854. (Pubitemid 32209572
36. Serra M, Pisu MG, Littera M, Papi G, Sanna E, Tuveri F, et al: Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 2000; 75: 732-740. (Pubitemid 30485455
37. Steimer T, Driscoll P, Schulz PE: Brain metabolism of progesterone, coping behaviour and emotional reactivity in male rats from two psychogenetically selected lines. J Neuroendocrinol 1997; 9: 169-175. (Pubitemid 27122582
38. Finn DA, Gee KW: The influence of estrus cycle on neurosteroid potency at the gammaaminobutyric acidA receptor complex. J Pharmacol Exp Ther 1993; 265: 1374-1379. (Pubitemid 23321044
39. Frye CA, Petralia SM, Rhodes ME: Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav 2000; 67: 587-596. (Pubitemid 32103570
40. Nyberg S, Backstrom T, Zingmark E, Purdy RH, Poromaa IS: Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol Endocrinol 2007; 23: 257-266. (Pubitemid 46897697
41. Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS: Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65: 805-815. (Pubitemid 351957706
42. Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson IM: Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol 2011; 162: 311-327
43. Smith SS, Shen H, Gong QH, Zhou X: Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits. Pharmacol Ther 2007; 116: 58-76. (Pubitemid 47391031
44. Zhu D, Birzniece V, Backstrom T, Wahlstrom G: Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br J Anaesth 2004; 93: 560-567. (Pubitemid 39359888
45. Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T: Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in Different endocrine states. Brain Res 1997; 764: 173-178. (Pubitemid 27380653
46. Genazzani AD, Luisi M, Malavasi B, Strucchi C, Luisi S, Casarosa E, et al: Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol 2002; 146: 347-356. (Pubitemid 34257645
47. Patchev VK, Hassan AH, Holsboer DF, Almeida OF: The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996; 15: 533-540. (Pubitemid 26400758
48. Rich-Edwards JW, Mohllajee AP, Kleinman K, Hacker MR, Majzoub J, Wright RJ, et al: Elevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depression. J Clin Endocrinol Metab 2008; 93: 1946-1951. (Pubitemid 351656542
49. Bados A, Gomez-Benito J, Balaguer G: The state-Trait anxiety inventory, trait version: Does it really measure anxiety?. J Pers Assess 2010; 92: 560-567
50. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M: Depression and anxiety during pregnancy and six months postpartum: A follow-up study. Acta Obstet Gynecol Scand 2006; 85: 937-944. (Pubitemid 44114952
51. Heron J, O'Connor TG, Evans J, Golding J, Glover V: The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 2004; 80: 65-73. (Pubitemid 38496530.